FK506 causes cellular and functional defects in human natural killer cells

Journal of Leukocyte Biology

Volumn 88, Issue 6, 2010, Pages 1089-1097

  Kim, Tae Jin ^a   Kim, Nayoung ^a   Kang, Hyoung Jin ^b   Kim, Eun Ok ^a   Kim, Sung Tae ^a   Ahn, Hyo Seop ^b   Bluestone, Jeffrey A ^c   Lee, Kyung Mi ^a  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IL 2 receptor; Nk receptors; STAT3; Tacrolimus

Indexed keywords

ALPHA4 INTEGRIN; CD48 ANTIGEN; DNAX ACCESSORY MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN; PROTYEIN 2B4; STAT3 PROTEIN; TACROLIMUS; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SCHOOL CHILD;

CELL ADHESION MOLECULES; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; STAT3 TRANSCRIPTION FACTOR; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649759743     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0310148     Document Type: Article

References (29)

1. Bowman, L. J., Brennan, D. C. (2008) The role of tacrolimus in renal transplantation. Expert Opin. Pharmacother. 9, 635-643.
2. Ratanatharathorn, V., Nash, R. A., Przepiorka, D., Devine, S. M., Klein, J. L., Weisdorf, D., Fay, J. W., Nademanee, A., Antin, J. H., Christiansen, N. P., van der Jagt, R., Herzig, R. H., Litzow, M. R., Wolff, S. N., Longo, W. L., Petersen, F. B., Karanes, C., Avalos, B., Storb, R., Buell, D. N., Maher, R. M., Fitzsimmons, W. E., Wingard, J. R. (1998) Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92, 2303-2314. (Pubitemid 28452971)
3. Nash, R. A., Antin, J. H., Karanes, C., Fay, J. W., Avalos, B. R., Yeager, A. M., Przepiorka, D., Davies, S., Petersen, F. B., Bartels, P., Buell, D., Fitzsimmons, W., Anasetti, C., Storb, R., Ratanatharathorn, V. (2000) Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96, 2062-2068.
4. Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H., et al. (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. (Tokyo) 40, 1256-1265. (Pubitemid 17138110)
5. Liu, J., Farmer Jr., J. D., Lane, W. S., Friedman, J., Weissman, I., Schreiber, S. L. (1991) Calcineurin is a common target of cyclophilin- cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
6. Lee, Y. R., Yang, I. H., Lee, Y. H., Im, S. A., Song, S., Li, H., Han, K., Kim, K., Eo, S. K., Lee, C. K. (2005) Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 105, 3951-3955.
7. Lee, Y. H., Lee, Y. R., Im, S. A., Park, S. I., Kim, K. H., Gerelchuluun, T., Song, S., Kim, K., Lee, C. K. (2007) Calcineurin inhibitors block MHC-restricted antigen presentation in vivo. J. Immunol. 179, 5711-5716.
8. Karre, K., Ljunggren, H. G., Piontek, G., Kiessling, R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675-678. (Pubitemid 16119452)
9. Fehniger, T. A., Cai, S. F., Cao, X., Bredemeyer, A. J., Presti, R. M., French, A. R., Ley, T. J. (2007) Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798-811.
10. Stetson, D. B., Mohrs, M., Reinhardt, R. L., Baron, J. L., Wang, Z. E., Gapin, L., Kronenberg, M., Locksley, R. M. (2003) Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069-1076.
11. Welniak, L. A., Blazar, B. R., Murphy, W. J. (2007) Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu. Rev. Immunol. 25, 139-170.
12. Pores-Fernando, A. T., Gaur, S., Doyon, M. Y., Zweifach, A. (2009) Calcineurin-dependent lytic granule exocytosis in NK-92 natural killer cells. Cell. Immunol. 254, 105-109.
13. Wasik, M., Gorski, A., Stepien-Sopniewska, B., Lagodzinski, Z. (1991) Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. Transplantation 51, 268-270.
14. Yoon, S. H., Yun, S. O., Park, J. Y., Won, H. Y., Kim, E. K., Sohn, H. J., Cho, H. I., Kim, T. G. (2009) Selective addition of CXCR3(+) CCR4(-) CD4(+) Th1 cells enhances generation of cytotoxic T cells by dendritic cells in vitro. Exp. Mol. Med. 41, 161-170.
15. Alter, G., Malenfant, J. M., Altfeld, M. (2004) CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294, 15-22. (Pubitemid 39626587)
16. Toomey, J. A., Gays, F., Foster, D., Brooks, C. G. (2003) Cytokine requirements for the growth and development of mouse NK cells in vitro. J. Leukoc. Biol. 74, 233-242.
17. Giavedoni, L. D., Velasquillo, M. C., Parodi, L. M., Hubbard, G. B., Hodara, V. L. (2000) Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J. Virol. 74, 1648-1657.
18. Ingels, S. C., Koenig, J., Scott, M. G. (1995) Stability of FK506 (tacrolimus) in whole-blood specimens. Clin. Chem. 41, 1320-1321.
19. Wingard, J. R., Nash, R. A., Przepiorka, D., Klein, J. L., Weisdorf, D. J., Fay, J. W., Zhu, J., Maher, R. M., Fitzsimmons, W. E., Ratanatharathorn, V. (1998) Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation. Biol. Blood Marrow Transplant. 4, 157-163.
20. Liao, X. C., Fournier, S., Killeen, N., Weiss, A., Allison, J. P., Littman, D. R. (1997) Itk negatively regulates induction of T cell proliferation by CD28 costimulation. J. Exp. Med. 186, 221-228.
21. Levy, D. E., Lee, C. K. (2002) What does Stat3 do? J. Clin. Invest. 109, 1143-1148.
22. Snyder, M., Huang, X. Y., Zhang, J. J. (2008) Identification of novel direct Stat3 target genes for control of growth and differentiation. J. Biol. Chem. 283, 3791-3798.
23. Lee, K. M., Forman, J. P., McNerney, M. E., Stepp, S., Kuppireddi, S., Guzior, D., Latchman, Y. E., Sayegh, M. H., Yagita, H., Park, C. K., Oh, S. B., Wulfing, C., Schatzle, J., Mathew, P. A., Sharpe, A. H., Kumar, V. (2006) Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood 107, 3181-3188.
24. Barber, D. F., Long, E. O. (2003) Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J. Immunol. 170, 294-299.
25. Latchman, Y., Reiser, H. (1998) Enhanced murine CD4+ T cell responses induced by the CD2 ligand CD48. Eur. J. Immunol. 28, 4325-4331.
26. Latchman, Y., McKay, P. F., Reiser, H. (1998) Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 161, 5809-5812. (Pubitemid 28535943)
27. Hiraoka, A., Ohashi, Y., Okamoto, S., Moriyama, Y., Nagao, T., Kodera, Y., Kanamaru, A., Dohy, H., Masaoka, T. (2001) Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 28, 181-185.
28. Wang, H., Grzywacz, B., Sukovich, D., McCullar, V., Cao, Q., Lee, A. B., Blazar, B. R., Cornfield, D. N., Miller, J. S., Verneris, M. R. (2007) The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood 110, 1530-1539.
29. Poggi, A., Massaro, A. M., Negrini, S., Contini, P., Zocchi, M. R. (2005) Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J. Immunol. 174, 2653-2660.